Study Stopped
My colleague did not want to continue the study
The Effect of Probiotic Supported Yogurt Consumption on Gastrointestinal Symptoms
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Probiotics have beneficial effect on Gastrointestinal Symptoms. The aim of this study is to determine the effect of probiotic yogurt consumptions on the people who have gastrointestinal symptoms mainly constipation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2022
CompletedFirst Posted
Study publicly available on registry
October 4, 2022
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedAugust 12, 2025
August 1, 2025
4 months
September 30, 2022
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The severity of gastrointestinal symptoms (mainly constipation) will decrease in the interventional group
We expect to see improvement in the gastrointestinal symptoms after consuming probiotic yogurt
4 weeks
Study Arms (2)
Control Group
NO INTERVENTIONThis group will be just follow-up for 4 weeks without any intervention
Interventional Group
EXPERIMENTALThis group will consume 125 g plain Activia Probiotic Yogurt without any aroma/fruit during 4 weeks/1 month
Interventions
Activia probiotic Yogurt will be consumed by participants in this group
Eligibility Criteria
You may qualify if:
- Living in Izmir
- Individuals who are having BMI between 18.5-24.9 kg / m2
- Having gastrointestinal symptoms according to Constipation Severity Scale and Bristol Stool Scale
You may not qualify if:
- Having diagnosed gastrointestinal disease
- Regular consumption of probiotic
- Using of drug that affects gastrointestinal system
- Presence of mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nezire
Famagusta, 99520, Cyprus
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nezire Ince
Eastern Mediterranean University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
September 30, 2022
First Posted
October 4, 2022
Study Start
September 1, 2024
Primary Completion
December 30, 2024
Study Completion
March 30, 2025
Last Updated
August 12, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share